Vanda Pharmaceuticals Inc. (FRA:VM4)
Germany
· Delayed Price · Currency is EUR 4.540
+0.080 (1.79%)
At close: Dec 5, 2025
Vanda Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -84.2 | -18.9 | 2.51 | 6.28 | 33.15 | 23.34 | Upgrade
|
| Depreciation & Amortization | 8.03 | 8.13 | 3.01 | 2.73 | 2.84 | 2.86 | Upgrade
|
| Loss (Gain) From Sale of Investments | -3.31 | -6.99 | -8.14 | -2.96 | 1.64 | -0.05 | Upgrade
|
| Stock-Based Compensation | 10.05 | 12.43 | 14.04 | 16.28 | 15.37 | 13.36 | Upgrade
|
| Other Operating Activities | -18.41 | -3.87 | 2.13 | 3.59 | 8.47 | 7.95 | Upgrade
|
| Change in Accounts Receivable | -7.82 | -13.01 | -0.71 | -1.09 | -2.47 | -3.77 | Upgrade
|
| Change in Inventory | -2.29 | -0.03 | -0.77 | -4.48 | -2.23 | -2.88 | Upgrade
|
| Change in Accounts Payable | 4.62 | 1.71 | -10.98 | 11.79 | 3.04 | 3.76 | Upgrade
|
| Change in Other Net Operating Assets | 11.5 | 4.78 | 11.72 | -0.15 | 4.4 | 7.2 | Upgrade
|
| Operating Cash Flow | -81.84 | -15.76 | 12.8 | 31.98 | 64.21 | 51.78 | Upgrade
|
| Operating Cash Flow Growth | - | - | -59.98% | -50.19% | 24.02% | 12.68% | Upgrade
|
| Capital Expenditures | -1.11 | -4.72 | -101.05 | -0.68 | -0.55 | -1.8 | Upgrade
|
| Investment in Securities | 55.1 | -12.71 | 88.99 | 50.6 | -76.14 | -39.7 | Upgrade
|
| Investing Cash Flow | 53.99 | -17.43 | -12.06 | 49.93 | -76.7 | -41.5 | Upgrade
|
| Long-Term Debt Repaid | - | -0.16 | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -1.51 | -0.16 | - | - | - | - | Upgrade
|
| Issuance of Common Stock | - | - | - | 0.73 | 3.55 | 5.63 | Upgrade
|
| Repurchase of Common Stock | -0.92 | - | - | - | - | - | Upgrade
|
| Financing Cash Flow | -2.42 | -0.16 | - | 0.73 | 3.55 | 5.63 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.2 | -0.16 | 0.05 | 0.27 | -0.09 | 0.05 | Upgrade
|
| Net Cash Flow | -30.48 | -33.51 | 0.79 | 82.91 | -9.02 | 15.96 | Upgrade
|
| Free Cash Flow | -82.95 | -20.48 | -88.25 | 31.31 | 63.66 | 49.98 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -50.83% | 27.38% | 11.24% | Upgrade
|
| Free Cash Flow Margin | -39.12% | -10.30% | -45.81% | 12.31% | 23.69% | 20.14% | Upgrade
|
| Free Cash Flow Per Share | -1.41 | -0.35 | -1.53 | 0.55 | 1.12 | 0.91 | Upgrade
|
| Cash Income Tax Paid | 2.4 | 2.4 | 3.6 | - | - | - | Upgrade
|
| Levered Free Cash Flow | -52.15 | -18.72 | -88.78 | 32.34 | 48.22 | 38.52 | Upgrade
|
| Unlevered Free Cash Flow | -49.79 | -18.72 | -88.78 | 32.34 | 48.22 | 38.52 | Upgrade
|
| Change in Working Capital | 6 | -6.56 | -0.75 | 6.07 | 2.74 | 4.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.